Idiopathic short stature (ISS) comprises a wide range of conditions associated with short stature that elude the conventional diagnostic work-up and are often caused by still largely unknown genetic variants. In the last decade, the improvement of diagnostic techniques has led to the discovery of causal mutations in genes involved in the function of the growth hormone (GH)/insulin-like growth factor-I (IGF-I) axis as well as in growth plate physiology. However, many cases of ISS remain idiopathic. In the future, the more frequent identification of the underlying causes will allow a better stratification of subjects and offer a tailored management. GH therapy has been proposed and approved in some countries for the treatment of children with ISS. To improve the efficacy of GH therapy, trials with GH combined with GnRH agonists, aromatase inhibitors, and even IGF-I have been conducted. This review aims to revise the current definition of ISS and discuss the management of children with ISS on the basis of the most recent evidence.

1.
Wit
JM
,
Clayton
PE
,
Rogol
AD
,
Savage
MO
,
Saenger
PH
,
Cohen
P
.
Idiopathic short stature: definition, epidemiology, and diagnostic evaluation
.
Growth Horm IGF Res
.
2008
Apr
;
18
(
2
):
89
110
.
[PubMed]
1096-6374
2.
Cohen
P
,
Rogol
AD
,
Deal
CL
,
Saenger
P
,
Reiter
EO
,
Ross
JL
, et al.;
2007 ISS Consensus Workshop participants
.
Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop
.
J Clin Endocrinol Metab
.
2008
Nov
;
93
(
11
):
4210
7
.
[PubMed]
0021-972X
3.
Dauber
A
,
Rosenfeld
RG
,
Hirschhorn
JN
.
Genetic evaluation of short stature
.
J Clin Endocrinol Metab
.
2014
Sep
;
99
(
9
):
3080
92
.
[PubMed]
0021-972X
4.
Plachy
L
,
Strakova
V
,
Elblova
L
,
Obermannova
B
,
Kolouskova
S
,
Snajderova
M
, et al.
High prevalence of growth plate gene variants in children with familial short stature treated with growth hormone
.
J Clin Endocrinol Metab
.
2019
Feb
;
104
(
10
):
4273
81
.
[PubMed]
0021-972X
5.
Murray
PG
,
Clayton
PE
,
Chernausek
SD
.
A genetic approach to evaluation of short stature of undetermined cause
.
Lancet Diabetes Endocrinol
.
2018
Jul
;
6
(
7
):
564
74
.
[PubMed]
2213-8587
6.
Hattori
A
,
Katoh-Fukui
Y
,
Nakamura
A
,
Matsubara
K
,
Kamimaki
T
,
Tanaka
H
, et al.
Next generation sequencing-based mutation screening of 86 patients with idiopathic short stature
.
Endocr J
.
2017
Oct
;
64
(
10
):
947
54
.
[PubMed]
0918-8959
7.
Ranke
MB
,
Schweizer
R
,
Elmlinger
MW
,
Weber
K
,
Binder
G
,
Schwarze
CP
, et al.
Significance of basal IGF-I, IGFBP-3 and IGFBP-2 measurements in the diagnostics of short stature in children
.
Horm Res
.
2000
;
54
(
2
):
60
8
.
[PubMed]
0301-0163
8.
Blair
JC
,
Camacho-Hübner
C
,
Miraki Moud
F
,
Rosberg
S
,
Burren
C
,
Lim
S
, et al.
Standard and low-dose IGF-I generation tests and spontaneous growth hormone secretion in children with idiopathic short stature
.
Clin Endocrinol (Oxf)
.
2004
Feb
;
60
(
2
):
163
8
.
[PubMed]
0300-0664
9.
Clayton
P
,
Bonnemaire
M
,
Dutailly
P
,
Maisonobe
P
,
Naudin
L
,
Pham
E
, et al.;
EPIGROW Study Group
.
Characterizing short stature by insulin-like growth factor axis status and genetic associations: results from the prospective, cross-sectional, epidemiogenetic EPIGROW study
.
J Clin Endocrinol Metab
.
2013
Jun
;
98
(
6
):
E1122
30
.
[PubMed]
0021-972X
10.
David
A
,
Hwa
V
,
Metherell
LA
,
Netchine
I
,
Camacho-Hübner
C
,
Clark
AJ
, et al.
Evidence for a continuum of genetic, phenotypic, and biochemical abnormalities in children with growth hormone insensitivity
.
Endocr Rev
.
2011
Aug
;
32
(
4
):
472
97
.
[PubMed]
0163-769X
11.
Derraik
JG
,
Miles
HL
,
Chiavaroli
V
,
Hofman
PL
,
Cutfield
WS
.
Idiopathic short stature and growth hormone sensitivity in prepubertal children
.
Clin Endocrinol (Oxf)
.
2019
Jul
;
91
(
1
):
110
7
.
[PubMed]
0300-0664
12.
Oostdijk
W
,
Grote
FK
,
de Muinck Keizer-Schrama
SM
,
Wit
JM
.
Diagnostic approach in children with short stature
.
Horm Res
.
2009
;
72
(
4
):
206
17
.
[PubMed]
0301-0163
13.
Flechtner
I
,
Lambot-Juhan
K
,
Teissier
R
,
Colmenares
A
,
Baujat
G
,
Beltrand
J
, et al.
Unexpected high frequency of skeletal dysplasia in idiopathic short stature and small for gestational age patients
.
Eur J Endocrinol
.
2014
Apr
;
170
(
5
):
677
84
.
[PubMed]
0804-4643
14.
Zahnleiter
D
,
Uebe
S
,
Ekici
AB
,
Hoyer
J
,
Wiesener
A
,
Wieczorek
D
, et al.
Rare copy number variants are a common cause of short stature
.
PLoS Genet
.
2013
;
9
(
3
):
e1003365
.
[PubMed]
1553-7390
15.
Ranke
MB
.
Treatment of children and adolescents with idiopathic short stature
.
Nat Rev Endocrinol
.
2013
Jun
;
9
(
6
):
325
34
.
[PubMed]
1759-5029
16.
Marouli
E
,
Graff
M
,
Medina-Gomez
C
,
Lo
KS
,
Wood
AR
,
Kjaer
TR
, et al.;
EPIC-InterAct Consortium
;
CHD Exome+ Consortium
;
ExomeBP Consortium
;
T2D-Genes Consortium
;
GoT2D Genes Consortium
;
Global Lipids Genetics Consortium
;
ReproGen Consortium
;
MAGIC Investigators
.
Rare and low-frequency coding variants alter human adult height
.
Nature
.
2017
Feb
;
542
(
7640
):
186
90
.
[PubMed]
0028-0836
17.
Weedon
MN
,
Lettre
G
,
Freathy
RM
,
Lindgren
CM
,
Voight
BF
,
Perry
JR
, et al.;
Diabetes Genetics Initiative
;
Wellcome Trust Case Control Consortium
.
A common variant of HMGA2 is associated with adult and childhood height in the general population
.
Nat Genet
.
2007
Oct
;
39
(
10
):
1245
50
.
[PubMed]
1061-4036
18.
Gudbjartsson
DF
,
Walters
GB
,
Thorleifsson
G
,
Stefansson
H
,
Halldorsson
BV
,
Zusmanovich
P
, et al.
Many sequence variants affecting diversity of adult human height
.
Nat Genet
.
2008
May
;
40
(
5
):
609
15
.
[PubMed]
1061-4036
19.
Benonisdottir
S
,
Oddsson
A
,
Helgason
A
,
Kristjansson
RP
,
Sveinbjornsson
G
,
Oskarsdottir
A
, et al.
Epigenetic and genetic components of height regulation
.
Nat Commun
.
2016
Nov
;
7
(
1
):
13490
.
[PubMed]
2041-1723
20.
Hirschhorn
JN
,
Lettre
G
.
Progress in genome-wide association studies of human height
.
Horm Res
.
2009
Apr
;
71
Suppl 2
:
5
13
.
[PubMed]
1423-0046
21.
Sanchez
JE
,
Perera
E
,
Baumbach
L
,
Cleveland
WW
.
Growth hormone receptor mutations in children with idiopathic short stature
.
J Clin Endocrinol Metab
.
1998
Nov
;
83
(
11
):
4079
83
.
[PubMed]
0021-972X
22.
Dias
C
,
Giordano
M
,
Frechette
R
,
Bellone
S
,
Polychronakos
C
,
Legault
L
, et al.
Genetic variations at the human growth hormone receptor (GHR) gene locus are associated with idiopathic short stature
.
J Cell Mol Med
.
2017
Nov
;
21
(
11
):
2985
99
.
[PubMed]
1582-1838
23.
Goddard
AD
,
Covello
R
,
Luoh
SM
,
Clackson
T
,
Attie
KM
,
Gesundheit
N
, et al.;
The Growth Hormone Insensitivity Study Group
.
Mutations of the growth hormone receptor in children with idiopathic short stature
.
N Engl J Med
.
1995
Oct
;
333
(
17
):
1093
8
.
[PubMed]
0028-4793
24.
Bonioli
E
,
Tarò
M
,
Rosa
CL
,
Citana
A
,
Bertorelli
R
,
Morcaldi
G
, et al.
Heterozygous mutations of growth hormone receptor gene in children with idiopathic short stature
.
Growth Horm IGF Res
.
2005
Dec
;
15
(
6
):
405
10
.
[PubMed]
1096-6374
25.
Salerno
M
,
Balestrieri
B
,
Matrecano
E
,
Officioso
A
,
Rosenfeld
RG
,
Di Maio
S
, et al.
Abnormal GH receptor signaling in children with idiopathic short stature
.
J Clin Endocrinol Metab
.
2001
Aug
;
86
(
8
):
3882
8
.
[PubMed]
0021-972X
26.
Kofoed
EM
,
Hwa
V
,
Little
B
,
Woods
KA
,
Buckway
CK
,
Tsubaki
J
, et al.
Growth hormone insensitivity associated with a STAT5b mutation
.
N Engl J Med
.
2003
Sep
;
349
(
12
):
1139
47
.
[PubMed]
0028-4793
27.
Batey
L
,
Moon
JE
,
Yu
Y
,
Wu
B
,
Hirschhorn
JN
,
Shen
Y
, et al.
A novel deletion of IGF1 in a patient with idiopathic short stature provides insight Into IGF1 haploinsufficiency
.
J Clin Endocrinol Metab
.
2014
Jan
;
99
(
1
):
E153
9
.
[PubMed]
0021-972X
28.
Yang
Y
,
Huang
H
,
Wang
W
,
Yang
L
,
Xie
LL
,
Huang
W
.
Association of insulin growth factor-1 receptor gene polymorphisms with genetic susceptibility to idiopathic short stature
.
Genet Mol Res
.
2013
Oct
;
12
(
4
):
4768
79
.
[PubMed]
1676-5680
29.
Domené
HM
,
Scaglia
PA
,
Martínez
AS
,
Keselman
AC
,
Karabatas
LM
,
Pipman
VR
, et al.
Heterozygous IGFALS gene variants in idiopathic short stature and normal children: impact on height and the IGF system
.
Horm Res Paediatr
.
2013
;
80
(
6
):
413
23
.
[PubMed]
1663-2818
30.
Dauber
A
,
Muñoz-Calvo
MT
,
Barrios
V
,
Domené
HM
,
Kloverpris
S
,
Serra-Juhé
C
, et al.
Mutations in pregnancy-associated plasma protein A2 cause short stature due to low IGF-I availability
.
EMBO Mol Med
.
2016
Apr
;
8
(
4
):
363
74
.
[PubMed]
1757-4676
31.
Baron
J
,
Sävendahl
L
,
De Luca
F
,
Dauber
A
,
Phillip
M
,
Wit
JM
, et al.
Short and tall stature: a new paradigm emerges
.
Nat Rev Endocrinol
.
2015
Dec
;
11
(
12
):
735
46
.
[PubMed]
1759-5029
32.
Wit
JM
,
Oostdijk
W
,
Losekoot
M
,
van Duyvenvoorde
HA
,
Ruivenkamp
CA
,
Kant
SG
.
MECHANISMS IN ENDOCRINOLOGY: novel genetic causes of short stature
.
Eur J Endocrinol
.
2016
Apr
;
174
(
4
):
R145
73
.
[PubMed]
0804-4643
33.
Rao
E
,
Weiss
B
,
Fukami
M
,
Rump
A
,
Niesler
B
,
Mertz
A
, et al.
Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome
.
Nat Genet
.
1997
May
;
16
(
1
):
54
63
.
[PubMed]
1061-4036
34.
Fukami
M
,
Seki
A
,
Ogata
T
.
SHOX Haploinsufficiency as a Cause of Syndromic and Nonsyndromic Short Stature
.
Mol Syndromol
.
2016
Apr
;
7
(
1
):
3
11
.
[PubMed]
1661-8769
35.
Binder
G
.
Short stature due to SHOX deficiency: genotype, phenotype, and therapy
.
Horm Res Paediatr
.
2011
Feb
;
75
(
2
):
81
9
.
[PubMed]
1663-2818
36.
Schmidt-Rohlfing
B
,
Schwöbel
B
,
Pauschert
R
,
Niethard
FU
.
Madelung deformity: clinical features, therapy and results
.
J Pediatr Orthop B
.
2001
Oct
;
10
(
4
):
344
8
.
[PubMed]
1060-152X
37.
Caliebe
J
,
Broekman
S
,
Boogaard
M
,
Bosch
CA
,
Ruivenkamp
CA
,
Oostdijk
W
, et al.
IGF1, IGF1R and SHOX mutation analysis in short children born small for gestational age and short children with normal birth size (idiopathic short stature)
.
Horm Res Paediatr
.
2012
;
77
(
4
):
250
60
.
[PubMed]
1663-2818
38.
Rappold
G
,
Blum
WF
,
Shavrikova
EP
,
Crowe
BJ
,
Roeth
R
,
Quigley
CA
, et al.
Genotypes and phenotypes in children with short stature: clinical indicators of SHOX haploinsufficiency
.
J Med Genet
.
2007
May
;
44
(
5
):
306
13
.
[PubMed]
0022-2593
39.
Karuppaiah
K
,
Yu
K
,
Lim
J
,
Chen
J
,
Smith
C
,
Long
F
, et al.
FGF signaling in the osteoprogenitor lineage non-autonomously regulates postnatal chondrocyte proliferation and skeletal growth
.
Development
.
2016
May
;
143
(
10
):
1811
22
.
[PubMed]
1011-6370
40.
Mamada
M
,
Yorifuji
T
,
Kurokawa
K
,
Kawai
M
,
Momoi
T
,
Nakahata
T
.
Prevalence of Mutations in the FGFR3 Gene in Individuals with Idiopathic Short Stature
.
Clin Pediatr Endocrinol
.
2006
;
15
(
2
):
61
4
.
[PubMed]
0918-5739
41.
Kant
SG
,
Cervenkova
I
,
Balek
L
,
Trantirek
L
,
Santen
GW
,
de Vries
MC
, et al.
A novel variant of FGFR3 causes proportionate short stature
.
Eur J Endocrinol
.
2015
Jun
;
172
(
6
):
763
70
.
[PubMed]
0804-4643
42.
Gkourogianni
A
,
Andrew
M
,
Tyzinski
L
,
Crocker
M
,
Douglas
J
,
Dunbar
N
, et al.
Clinical Characterization of Patients With Autosomal Dominant Short Stature due to Aggrecan Mutations
.
J Clin Endocrinol Metab
.
2017
Feb
;
102
(
2
):
460
9
.
[PubMed]
1945-7197
43.
Hauer
NN
,
Sticht
H
,
Boppudi
S
,
Büttner
C
,
Kraus
C
,
Trautmann
U
, et al.
Genetic screening confirms heterozygous mutations in ACAN as a major cause of idiopathic short stature
.
Sci Rep
.
2017
Sep
;
7
(
1
):
12225
.
[PubMed]
2045-2322
44.
Olney
RC
: C-type natriuretic peptide in growth: a new paradigm. Growth Horm IGF Res
2006
;16 Suppl A:S6-14.
45.
Vasques
GA
,
Amano
N
,
Docko
AJ
,
Funari
MF
,
Quedas
EP
,
Nishi
MY
, et al.
Heterozygous mutations in natriuretic peptide receptor-B (NPR2) gene as a cause of short stature in patients initially classified as idiopathic short stature
.
J Clin Endocrinol Metab
.
2013
Oct
;
98
(
10
):
E1636
44
.
[PubMed]
0021-972X
46.
Krejci
P
,
Masri
B
,
Fontaine
V
,
Mekikian
PB
,
Weis
M
,
Prats
H
, et al.
Interaction of fibroblast growth factor and C-natriuretic peptide signaling in regulation of chondrocyte proliferation and extracellular matrix homeostasis
.
J Cell Sci
.
2005
Nov
;
118
(
Pt 21
):
5089
100
.
[PubMed]
0021-9533
47.
Hisado-Oliva
A
,
Ruzafa-Martin
A
,
Sentchordi
L
,
Funari
MF
,
Bezanilla-López
C
,
Alonso-Bernáldez
M
, et al.
Mutations in C-natriuretic peptide (NPPC): a novel cause of autosomal dominant short stature
.
Genet Med
.
2018
Jan
;
20
(
1
):
91
7
.
[PubMed]
1098-3600
48.
van Duyvenvoorde
HA
,
Lui
JC
,
Kant
SG
,
Oostdijk
W
,
Gijsbers
AC
,
Hoffer
MJ
, et al.
Copy number variants in patients with short stature
.
Eur J Hum Genet
.
2014
May
;
22
(
5
):
602
9
.
[PubMed]
1018-4813
49.
Hu
G
,
Fan
Y
,
Wang
L
,
Yao
RE
,
Huang
X
,
Shen
Y
, et al.
Copy number variations in 119 Chinese children with idiopathic short stature identified by the custom genome-wide microarray
.
Mol Cytogenet
.
2016
Feb
;
9
(
1
):
16
.
[PubMed]
1755-8166
50.
Singh
H
,
Tiwari
P
,
Bhavi
V
,
Chaudhary
PS
,
Suravajhala
P
,
Mohan
MK
, et al.
Application of Chromosomal Microarray for Evaluation of Idiopathic Short Stature in Asian Indian Children: A Pilot Study
.
Indian J Endocrinol Metab
.
2018
Jan-Feb
;
22
(
1
):
100
6
.
[PubMed]
2230-8210
51.
Guo
MH
,
Shen
Y
,
Walvoord
EC
,
Miller
TC
,
Moon
JE
,
Hirschhorn
JN
, et al.
Whole exome sequencing to identify genetic causes of short stature
.
Horm Res Paediatr
.
2014
;
82
(
1
):
44
52
.
[PubMed]
1663-2818
52.
Hauer
NN
,
Popp
B
,
Schoeller
E
,
Schuhmann
S
,
Heath
KE
,
Hisado-Oliva
A
, et al.
Clinical relevance of systematic phenotyping and exome sequencing in patients with short stature
.
Genet Med
.
2018
Jun
;
20
(
6
):
630
8
.
[PubMed]
1098-3600
53.
Huang
Z
,
Sun
Y
,
Fan
Y
,
Wang
L
,
Liu
H
,
Gong
Z
, et al.
Genetic Evaluation of 114 Chinese Short Stature Children in the Next Generation Era: a Single Center Study
.
Cell Physiol Biochem
.
2018
;
49
(
1
):
295
305
.
[PubMed]
1015-8987
54.
Piedrahita
JA
.
The role of imprinted genes in fetal growth abnormalities
.
Birth Defects Res A Clin Mol Teratol
.
2011
Aug
;
91
(
8
):
682
92
.
[PubMed]
1542-0752
55.
Ranke
MB
,
Grauer
ML
,
Kistner
K
,
Blum
WF
,
Wollmann
HA
.
Spontaneous adult height in idiopathic short stature
.
Horm Res
.
1995
;
44
(
4
):
152
7
.
[PubMed]
0301-0163
56.
Rekers-Mombarg
LT
,
Wit
JM
,
Massa
GG
,
Ranke
MB
,
Buckler
JM
,
Butenandt
O
, et al.;
European Study Group
.
Spontaneous growth in idiopathic short stature
.
Arch Dis Child
.
1996
Sep
;
75
(
3
):
175
80
.
[PubMed]
0003-9888
57.
Van Vliet
G
,
Styne
DM
,
Kaplan
SL
,
Grumbach
MM
.
Growth hormone treatment for short stature
.
N Engl J Med
.
1983
Oct
;
309
(
17
):
1016
22
.
[PubMed]
0028-4793
58.
Rudman
D
,
Kutner
MH
,
Blackston
RD
,
Cushman
RA
,
Bain
RP
,
Patterson
JH
.
Children with normal-variant short stature: treatment with human growth hormone for six months
.
N Engl J Med
.
1981
Jul
;
305
(
3
):
123
31
.
[PubMed]
0028-4793
59.
Cianfarani
S
,
Spadoni
GL
,
Scirè
G
,
Manca Bitti
ML
,
Galasso
C
,
Benvenuti
S
, et al.
[Pretreatment growth rate and response to therapy with growth hormone (HGH)]
.
Minerva Pediatr
.
1987
Oct
;
39
(
19
):
757
61
.
[PubMed]
0026-4946
60.
Spagnoli
A
,
Spadoni
GL
,
Cianfarani
S
,
Pasquino
AM
,
Troiani
S
,
Boscherini
B
.
Prediction of the outcome of growth hormone therapy in children with idiopathic short stature. A multivariate discriminant analysis
.
J Pediatr
.
1995
Jun
;
126
(
6
):
905
9
.
[PubMed]
0022-3476
61.
Hopwood
NJ
,
Hintz
RL
,
Gertner
JM
,
Attie
KM
,
Johanson
AJ
,
Baptista
J
, et al.
Growth response of children with non-growth-hormone deficiency and marked short stature during three years of growth hormone therapy
.
J Pediatr
.
1993
Aug
;
123
(
2
):
215
22
.
[PubMed]
0022-3476
62.
Hintz
RL
.
Growth hormone treatment of idiopathic short stature
.
Horm Res
.
1996
;
46
(
4-5
):
208
14
.
[PubMed]
0301-0163
63.
Hintz
RL
,
Attie
KM
,
Baptista
J
,
Roche
A
;
Genentech Collaborative Group
.
Effect of growth hormone treatment on adult height of children with idiopathic short stature
.
N Engl J Med
.
1999
Feb
;
340
(
7
):
502
7
.
[PubMed]
0028-4793
64.
Bang
P
,
Ahmed
SF
,
Argente
J
,
Backeljauw
P
,
Bettendorf
M
,
Bona
G
, et al.
Identification and management of poor response to growth-promoting therapy in children with short stature
.
Clin Endocrinol (Oxf)
.
2012
Aug
;
77
(
2
):
169
81
.
[PubMed]
0300-0664
65.
Ranke
MB
,
Lindberg
A
,
Price
DA
,
Darendeliler
F
,
Albertsson-Wikland
K
,
Wilton
P
, et al.;
KIGS International Board
.
Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature
.
Horm Res
.
2007
;
68
(
2
):
53
62
.
[PubMed]
1423-0046
66.
Deodati
A
,
Cianfarani
S
.
Impact of growth hormone therapy on adult height of children with idiopathic short stature: systematic review
.
BMJ
.
2011
Mar
;
342
mar11 1
:
c7157
.
[PubMed]
0959-8138
67.
Grimberg
A
,
DiVall
SA
,
Polychronakos
C
,
Allen
DB
,
Cohen
LE
,
Quintos
JB
, et al.;
Drug and Therapeutics Committee and Ethics Committee of the Pediatric Endocrine Society
.
Guidelines for Growth Hormone and Insulin-Like Growth Factor-I Treatment in Children and Adolescents: Growth Hormone Deficiency, Idiopathic Short Stature, and Primary Insulin-Like Growth Factor-I Deficiency
.
Horm Res Paediatr
.
2016
;
86
(
6
):
361
97
.
[PubMed]
1663-2818
68.
Allen
DB
,
Cuttler
L
.
Clinical practice. Short stature in childhood—challenges and choices
.
N Engl J Med
.
2013
Mar
;
368
(
13
):
1220
8
.
[PubMed]
0028-4793
69.
van Gool
SA
,
Kamp
GA
,
Odink
RJ
,
de Muinck Keizer-Schrama
SM
,
Delemarre-van de Waal
HA
,
Oostdijk
W
, et al.
High-dose GH treatment limited to the prepubertal period in young children with idiopathic short stature does not increase adult height
.
Eur J Endocrinol
.
2010
Apr
;
162
(
4
):
653
60
.
[PubMed]
0804-4643
70.
Carel
JC
,
Ecosse
E
,
Landier
F
,
Meguellati-Hakkas
D
,
Kaguelidou
F
,
Rey
G
, et al.
Long-term mortality after recombinant growth hormone treatment for isolated growth hormone deficiency or childhood short stature: preliminary report of the French SAGhE study
.
J Clin Endocrinol Metab
.
2012
Feb
;
97
(
2
):
416
25
.
[PubMed]
0021-972X
71.
Sävendahl
L
,
Maes
M
,
Albertsson-Wikland
K
,
Borgström
B
,
Carel
JC
,
Henrard
S
, et al.
Long-term mortality and causes of death in isolated GHD, ISS, and SGA patients treated with recombinant growth hormone during childhood in Belgium, The Netherlands, and Sweden: preliminary report of 3 countries participating in the EU SAGhE study
.
J Clin Endocrinol Metab
.
2012
Feb
;
97
(
2
):
E213
7
.
[PubMed]
0021-972X
72.
Cianfarani
S
.
Long-term safety of growth hormone therapy: still a controversial issue
.
Front Endocrinol (Lausanne)
.
2012
Sep
;
3
:
115
.
[PubMed]
1664-2392
73.
Poidvin
A
,
Touzé
E
,
Ecosse
E
,
Landier
F
,
Béjot
Y
,
Giroud
M
, et al.
Growth hormone treatment for childhood short stature and risk of stroke in early adulthood
.
Neurology
.
2014
Aug
;
83
(
9
):
780
6
.
[PubMed]
0028-3878
74.
Albertsson-Wikland
K
,
Martensson
A
,
Savendahl
L
,
Niklasson
A
,
Bang
P
,
Dahlgren
J
, et al.
Mortality is not increased in rhGH-treated patients when adjusting for birth characteristics
.
J Clin Endocrinol Metab
.
2016
;
•••
:
jc20153951
.0021-972X
75.
Swerdlow
AJ
,
Cooke
R
,
Beckers
D
,
Borgström
B
,
Butler
G
,
Carel
JC
, et al.
Cancer Risks in Patients Treated With Growth Hormone in Childhood: The SAGhE European Cohort Study
.
J Clin Endocrinol Metab
.
2017
May
;
102
(
5
):
1661
72
.
[PubMed]
0021-972X
76.
Poidvin
A
,
Carel
JC
,
Ecosse
E
,
Levy
D
,
Michon
J
,
Coste
J
.
Increased risk of bone tumors after growth hormone treatment in childhood: A population-based cohort study in France
.
Cancer Med
.
2018
Jun
;
7
(
7
):
3465
73
.
[PubMed]
2045-7634
77.
Wit
JM
,
Oostdijk
W
.
Novel approaches to short stature therapy
.
Best Pract Res Clin Endocrinol Metab
.
2015
Jun
;
29
(
3
):
353
66
.
[PubMed]
1521-690X
78.
de Lange
WE
,
Snoep
MC
,
Doorenbos
H
.
The effect of short-term testosterone treatment in boys with delayed puberty
.
Acta Endocrinol (Copenh)
.
1979
May
;
91
(
1
):
177
83
.
[PubMed]
0001-5598
79.
Stanhope
R
,
Preece
MA
.
Management of constitutional delay of growth and puberty
.
Arch Dis Child
.
1988
Sep
;
63
(
9
):
1104
10
.
[PubMed]
0003-9888
80.
Butler
GE
,
Sellar
RE
,
Walker
RF
,
Hendry
M
,
Kelnar
CJ
,
Wu
FC
.
Oral testosterone undecanoate in the management of delayed puberty in boys: pharmacokinetics and effects on sexual maturation and growth
.
J Clin Endocrinol Metab
.
1992
Jul
;
75
(
1
):
37
44
.
[PubMed]
0021-972X
81.
Kaplowitz
PB
.
Diagnostic value of testosterone therapy in boys with delayed puberty
.
Am J Dis Child
.
1989
Jan
;
143
(
1
):
116
20
.
[PubMed]
0002-922X
82.
Büyükgebiz
A
.
Treatment of constitutional delayed puberty with a combination of testosterone esters
.
Turk J Pediatr
.
1993
Oct-Dec
;
35
(
4
):
271
5
.
[PubMed]
0041-4301
83.
Lawaetz
JG
,
Hagen
CP
,
Mieritz
MG
,
Blomberg Jensen
M
,
Petersen
JH
,
Juul
A
.
Evaluation of 451 Danish boys with delayed puberty: diagnostic use of a new puberty nomogram and effects of oral testosterone therapy
.
J Clin Endocrinol Metab
.
2015
Apr
;
100
(
4
):
1376
85
.
[PubMed]
0021-972X
84.
Yanovski
JA
,
Rose
SR
,
Municchi
G
,
Pescovitz
OH
,
Hill
SC
,
Cassorla
FG
, et al.
Treatment with a luteinizing hormone-releasing hormone agonist in adolescents with short stature
.
N Engl J Med
.
2003
Mar
;
348
(
10
):
908
17
.
[PubMed]
0028-4793
85.
Municchi
G
,
Rose
SR
,
Pescovitz
OH
,
Barnes
KM
,
Cassorla
FG
,
Cutler
GB
 Jr
.
Effect of deslorelin-induced pubertal delay on the growth of adolescents with short stature and normally timed puberty: preliminary results
.
J Clin Endocrinol Metab
.
1993
Nov
;
77
(
5
):
1334
9
.
[PubMed]
0021-972X
86.
Carel
JC
,
Hay
F
,
Coutant
R
,
Rodrigue
D
,
Chaussain
JL
.
Gonadotropin-releasing hormone agonist treatment of girls with constitutional short stature and normal pubertal development
.
J Clin Endocrinol Metab
.
1996
Sep
;
81
(
9
):
3318
22
.
[PubMed]
0021-972X
87.
Carel
JC
,
Eugster
EA
,
Rogol
A
,
Ghizzoni
L
,
Palmert
MR
,
Antoniazzi
F
, et al.;
ESPE-LWPES GnRH Analogs Consensus Conference Group
.
Consensus statement on the use of gonadotropin-releasing hormone analogs in children
.
Pediatrics
.
2009
Apr
;
123
(
4
):
e752
62
.
[PubMed]
0031-4005
88.
Mazur
T
,
Clopper
RR
.
Pubertal disorders. Psychology and clinical management
.
Endocrinol Metab Clin North Am
.
1991
Mar
;
20
(
1
):
211
30
.
[PubMed]
0889-8529
89.
Balducci
R
,
Toscano
V
,
Mangiantini
A
,
Municchi
G
,
Vaccaro
F
,
Picone
S
, et al.
Adult height in short normal adolescent girls treated with gonadotropin-releasing hormone analog and growth hormone
.
J Clin Endocrinol Metab
.
1995
Dec
;
80
(
12
):
3596
600
.
[PubMed]
0021-972X
90.
Kamp
GA
,
Mul
D
,
Waelkens
JJ
,
Jansen
M
,
Delemarre-van de Waal
HA
,
Verhoeven-Wind
L
, et al.
A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation
.
J Clin Endocrinol Metab
.
2001
Jul
;
86
(
7
):
2969
75
.
[PubMed]
0021-972X
91.
Pasquino
AM
,
Pucarelli
I
,
Roggini
M
,
Segni
M
.
Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone
.
J Clin Endocrinol Metab
.
2000
Feb
;
85
(
2
):
619
22
.
[PubMed]
0021-972X
92.
Lazar
L
,
Levy
S
,
Oron
T
,
Meyerovitch
J
,
de Vries
L
,
Shalitin
S
, et al.
The beneficial effect of combined GH/GnRHa therapy in increasing adult height outcome in ISS children
.
J Clin Endocrinol Metab
.
2019
Aug
;
104
(
8
):
3287
95
.
[PubMed]
0021-972X
93.
van Gool
SA
,
Kamp
GA
,
Visser-van Balen
H
,
Mul
D
,
Waelkens
JJ
,
Jansen
M
, et al.
Final height outcome after three years of growth hormone and gonadotropin-releasing hormone agonist treatment in short adolescents with relatively early puberty
.
J Clin Endocrinol Metab
.
2007
Apr
;
92
(
4
):
1402
8
.
[PubMed]
0021-972X
94.
Benabbad
I
,
Rosilio
M
,
Tauber
M
,
Paris
E
,
Paulsen
A
,
Berggren
L
, et al.;
Phoenix Study Group
.
Growth hormone in combination with leuprorelin in pubertal children with idiopathic short stature
.
Endocr Connect
.
2018
May
;
7
(
5
):
708
18
.
[PubMed]
2049-3614
95.
Weise
M
,
De-Levi
S
,
Barnes
KM
,
Gafni
RI
,
Abad
V
,
Baron
J
.
Effects of estrogen on growth plate senescence and epiphyseal fusion
.
Proc Natl Acad Sci USA
.
2001
Jun
;
98
(
12
):
6871
6
.
[PubMed]
0027-8424
96.
Nilsson
O
,
Weise
M
,
Landman
EB
,
Meyers
JL
,
Barnes
KM
,
Baron
J
.
Evidence that estrogen hastens epiphyseal fusion and cessation of longitudinal bone growth by irreversibly depleting the number of resting zone progenitor cells in female rabbits
.
Endocrinology
.
2014
Aug
;
155
(
8
):
2892
9
.
[PubMed]
0013-7227
97.
Wickman
S
,
Sipilä
I
,
Ankarberg-Lindgren
C
,
Norjavaara
E
,
Dunkel
L
.
A specific aromatase inhibitor and potential increase in adult height in boys with delayed puberty: a randomised controlled trial
.
Lancet
.
2001
Jun
;
357
(
9270
):
1743
8
.
[PubMed]
0140-6736
98.
Cianfarani
S
.
Role of hormones in puberty
.
Lancet
.
2001
Oct
;
358
(
9291
):
1459
60
.
[PubMed]
0140-6736
99.
Hero
M
,
Norjavaara
E
,
Dunkel
L
.
Inhibition of estrogen biosynthesis with a potent aromatase inhibitor increases predicted adult height in boys with idiopathic short stature: a randomized controlled trial
.
J Clin Endocrinol Metab
.
2005
Dec
;
90
(
12
):
6396
402
.
[PubMed]
0021-972X
100.
Krebs
A
,
Moske-Eick
O
,
Doerfer
J
,
Roemer-Pergher
C
,
van der Werf-Grohmann
N
,
Schwab
KO
.
Marked increase of final height by long-term aromatase inhibition in a boy with idiopathic short stature
.
J Pediatr Endocrinol Metab
.
2012
;
25
(
5-6
):
581
5
.
[PubMed]
0334-018X
101.
Mauras
N
,
Ross
JL
,
Gagliardi
P
,
Yu
YM
,
Hossain
J
,
Permuy
J
, et al.
Randomized Trial of Aromatase Inhibitors, Growth Hormone, or Combination in Pubertal Boys with Idiopathic, Short Stature
.
J Clin Endocrinol Metab
.
2016
Dec
;
101
(
12
):
4984
93
.
[PubMed]
0021-972X
102.
Hero
M
,
Toiviainen-Salo
S
,
Wickman
S
,
Mäkitie
O
,
Dunkel
L
.
Vertebral morphology in aromatase inhibitor-treated males with idiopathic short stature or constitutional delay of puberty
.
J Bone Miner Res
.
2010
Jul
;
25
(
7
):
1536
43
.
[PubMed]
0884-0431
103.
Dunkel
L
.
Off-label use of aromatase inhibitors to promote taller stature: is it safe
.
Horm Res Paediatr
.
2010
;
74
(
6
):
436
7
.
[PubMed]
1663-2818
104.
Backeljauw
PF
,
Miller
BS
,
Dutailly
P
,
Houchard
A
,
Lawson
E
,
Hale
DE
, et al.;
MS316 Study Group
.
Recombinant human growth hormone plus recombinant human insulin-like growth factor-1 coadministration therapy in short children with low insulin-like growth factor-1 and growth hormone sufficiency: results from a randomized, multicenter, open-label, parallel-group, active treatment-controlled trial
.
Horm Res Paediatr
.
2015
;
83
(
4
):
268
79
.
[PubMed]
1663-2818
105.
Coste
J
,
Pouchot
J
,
Carel
JC
.
Height and health-related quality of life: a nationwide population study
.
J Clin Endocrinol Metab
.
2012
Sep
;
97
(
9
):
3231
9
.
[PubMed]
0021-972X
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.